231 related articles for article (PubMed ID: 10521679)
1. The frequency of illegitimate TCRbeta/gamma gene recombination in human lymphocytes: influence of age, environmental exposure and cytostatic treatment, and correlation with frequencies of t(14;18) and hprt mutation.
Meydan D; Nilsson T; Törnblom M; Hagmar L; Hellgren D; Fuscoe JC; Lambert B
Mutat Res; 1999 Aug; 444(2):393-403. PubMed ID: 10521679
[TBL] [Abstract][Full Text] [Related]
2. DNA sequence analysis of interlocus recombination between the human T-cell receptor gamma variable (GV) and beta diversity-joining (BD/BJ) sequences on chromosome 7 (inversion 7).
Ballinger SW; Judice SA; Nicklas JA; Albertini RJ; O'Neill JP
Environ Mol Mutagen; 2002; 40(2):85-92. PubMed ID: 12203400
[TBL] [Abstract][Full Text] [Related]
3. Variations in the frequency of T-cell receptor beta/gamma-interlocus recombination in long-term cultures of non-irradiated and X- and gamma-irradiated human lymphocytes.
Meydan D; Hellgren D; Lambert B
Int J Radiat Biol; 1998 Dec; 74(6):697-703. PubMed ID: 9881714
[TBL] [Abstract][Full Text] [Related]
4. Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults.
Scheerer JB; Xi L; Knapp GW; Setzer RW; Bigbee WL; Fuscoe JC
Mutat Res; 1999 Dec; 431(2):291-303. PubMed ID: 10635995
[TBL] [Abstract][Full Text] [Related]
5. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
6. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
[TBL] [Abstract][Full Text] [Related]
7. HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts.
Perera FP; Tang DL; O'Neill JP; Bigbee WL; Albertini RJ; Santella R; Ottman R; Tsai WY; Dickey C; Mooney LA
Carcinogenesis; 1993 May; 14(5):969-73. PubMed ID: 8504491
[TBL] [Abstract][Full Text] [Related]
8. Influence of smoking and donor age on the spectrum of in vivo mutation at the HPRT-locus in T lymphocytes of healthy adults.
Podlutsky A; Hou SM; Nyberg F; Pershagen G; Lambert B
Mutat Res; 1999 Dec; 431(2):325-39. PubMed ID: 10635998
[TBL] [Abstract][Full Text] [Related]
9. Mutational spectra at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus in T-lymphocytes of nonsmoking and smoking lung cancer patients.
Hackman P; Hou SM; Nyberg F; Pershagen G; Lambert B
Mutat Res; 2000 Jun; 468(1):45-61. PubMed ID: 10863157
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of styrene exposure in lamination workers: levels of O6-guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes.
Vodicka P; Bastlová T; Vodicková L; Peterková K; Lambert B; Hemminki K
Carcinogenesis; 1995 Jul; 16(7):1473-81. PubMed ID: 7614680
[TBL] [Abstract][Full Text] [Related]
11. The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy.
Fuscoe JC; Knapp GW; Hanley NM; Setzer RW; Sandlund JT; Pui CH; Relling MV
Mutat Res; 1998 Nov; 419(1-3):107-21. PubMed ID: 9804912
[TBL] [Abstract][Full Text] [Related]
12. Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies.
Bigbee WL; Fuscoe JC; Grant SG; Jones IM; Gorvad AE; Harrington-Brock K; Strout CL; Thomas CB; Moore MM
Mutat Res; 1998 Feb; 397(2):119-36. PubMed ID: 9541637
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes.
Fuscoe JC
Methods Mol Biol; 2020; 2102():361-370. PubMed ID: 31989567
[TBL] [Abstract][Full Text] [Related]
14. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
Fuscoe JC; Vira LK; Collard DD; Moore MM
Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
Fuscoe JC
Methods Mol Biol; 2005; 291():171-8. PubMed ID: 15502222
[TBL] [Abstract][Full Text] [Related]
16. Impact of maternal lifestyle factors on newborn HPRT mutant frequencies and molecular spectrum--initial results from the Prenatal Exposures and Preeclampsia Prevention (PEPP) Study.
Bigbee WL; Day RD; Grant SG; Keohavong P; Xi L; Zhang L; Ness RB
Mutat Res; 1999 Dec; 431(2):279-89. PubMed ID: 10635994
[TBL] [Abstract][Full Text] [Related]
17. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
18. In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients.
Albertini MR; King DM; Newton MA; Vacek PM
Mutat Res; 2001 May; 476(1-2):83-97. PubMed ID: 11336986
[TBL] [Abstract][Full Text] [Related]
19. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons.
Perera FP; Dickey C; Santella R; O'Neill JP; Albertini RJ; Ottman R; Tsai WY; Mooney LA; Savela K; Hemminki K
Carcinogenesis; 1994 Dec; 15(12):2905-10. PubMed ID: 8001254
[TBL] [Abstract][Full Text] [Related]
20. Novel types of mutation identified at the hprt locus of human T-lymphocytes.
Hou SM
Mutat Res; 1994 Jul; 308(1):23-31. PubMed ID: 7516483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
